SYRE Earnings

Quarterly EPS
$-1.06
Q3 2024
$-0.79
Q4 2024
$-0.60
Q1 2025
$-0.49
Q2 2025
$-0.15
Q3 2025
$-0.69
Q4 2025
$-0.74
Q1 2026
$-0.36
Q2 2026
Latest RevenueN/A
Latest Net Income-36200000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.360-36200000+26.5%
Q1 2026-$0.740-69005000-23.3%
Q4 2025-$0.690-62530000+12.7%
Q3 2025-$0.150-11183000+85.8%
Q2 2025-$0.490-36717000+16.9%
Q1 2025-$0.600-44773000+16.7%
Q4 2024-$0.790-56296000+66.4%
Q3 2024-$1.060-69028000
Q2 2024-$0.590-38837000
Q1 2024-$0.720-43857000
Q4 2023-$2.350-63180000
Spyre Therapeutics (SYRE) — Earnings